Abstract
ObjectivesTo assess cluster of differentiation 93 (CD93) protein serum level in psoriasis cases and its role in the disease pathogenesis.BackgroundPsoriasis is a common, chronic inflammatory skin disease. It is a complex multifactorial condition related to a combination of genetic, environmental, and immunological factors; hence, this study was established to study the role of CD93 in the psoriasis pathogenesis.Patients and methodsThis prospective study was carried out during the period from June 2018 to December 2018. This case–control study was conducted on 30 patients with psoriasis vulgaris and 20 age-matched and sex-matched healthy volunteers as a control group. Cases were selected from the Dermatology Outpatient Clinic at Menoufia University Hospital during the period from June 2018 to December 2018. Control were selected from the healthy staff of Menoufia University Hospital. The laboratory part of the study was done at the Biochemistry Department of Menoufia Faculty of Medicine.ResultsThere were no significant differences in CD93 protein levels in serum between patients with psoriasis and controls.ConclusionThere were no differences in CD93 protein expression in serum among psoriasis cases and control group.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
